Jim Cramer Blog

Bullish calls:
CVS Caremark (CVS): 'I think it's unbelievably strong ... you should get in right here. ... CVS remains one of my favorite stocks in this environment.'), Hewlett-Packard (HPQ): 'That was a monster-good quarter. That was an All-Aboard quarter. ... That company is smoking. ... It's not done. I wanna own Hewlett-Packard ... and so should you.' Monster Worldwide (MNST): 'I thought that the new management team would turn things around ... Monster, I still think, is being set up to be bought.' St. Jude Medical (STJ): 'If you want to be in that cohort, it's gotta be S-T-J.' Freeport-McMoran (FCX): 'I'm willing to have you in Freeport (FCX - Cramer's Take - Stockpickr - Rating), cause that's copper and gold.' Transocean (RIG): 'This is a great opportunity. ... In the last three days ... Transocean went from $138 to $127 because they did financing.' Schlumberger (SLB) Raytheon (RTN) Wolverine World Wide (WWW) Nike (NKE) Vimpel Communications (VIP) Shaw Group (SGR) Countrywide Financial (CFC): 'It's a very technical situation. ... If the Fed cuts 50 basis points, Countrywide will work.'
Bearish calls:
Sysco (SYY): 'It's OK ... as long as the consumer's out there spending ... going to a lot of restaurants ... the problem is they're not going to restaurants as much. Don'tBuy.' Boston Scientific (BSX): 'Let me be very clear. I have disliked Boston Scientific for more than 10 points.' Titanium Metals (TIE) Taser (TASR): 'In this market, it's too hard for me. ... I do not want to buy Taser here. Don'tBuy.'

Labels: BSX, CFC, CVS, FCX, HPQ, Jim Cramer, Lightning Round, Mad Money, MNST, NKE, RIG, RTN, SGR, SLB, STJ, SYY, TASR, TIE, VIP, WWW

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Abercrombie & Fitch (NYSE:ANF - News). ANF's PowerRating (for Traders) is 6.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Laboratory Corporation (NYSE:LH - News). LH's PowerRating (for Traders) is 6.
Bearish
Laps Up 5% or More: These are stocks that lap up by 5% or more and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that lap up by more than 5% have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Valueclick (NasdaqGS:VCLK - News). VCLK's PowerRating (for Traders) is 3.
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Boston Scientific (NYSE:BSX - News). BSX's PowerRating (for Traders) is 2.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Ryerson (NYSE:RYI - News). RYI's PowerRating (for Traders) is 4.
2-Period RSI Above 98: These are stocks that have a 2-day RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
NovaStar Financial (NYSE:NFI - News). NFK's PowerRating (for Traders) is 3.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Krispy Kreme (NYSE:KKD - News). KKD's PowerRating (for Traders) is 2.
Published By TradingMarkets.com

Labels: ANF, Boston Scientific Corp., BSX, Hot Stocks, KKD, LH, NFI, Novastar Financial Inc., Ryerson, RYI, Valueclick Inc., VCLK

Bullish calls:
Raytheon (NYSE: RTN - News): 'Raytheon's probably the cheapest.'General Dynamics (GDNorthrop Grumman (NYSE: NOC - News)Lockheed Martin (NYSE: LMT - News)Frontline (NYSE: FRO - News):'Yours is a winner. Frontline is a buy. I see the stock went down today, but, you know, a lot of stocks went down today. That's a good one.'UnitedHealth (NYSE: UNH - News): 'Understand, I've owned this stock for a couple of years for my charitable trust. This is precisely the kind of stock that does well on a slowdown. ... I want to buy the stock.'Norfolk Southern (NYSE: NSC - News): 'Every railroad stock has been killed. ... All of them are owned by very big hedge funds. ... People say to themselves, 'I guess all the hedge funds are getting killed.' That is not true. ... I still like the stock.'Trinity Industries (NYSE: TRN - News): 'When this mortgage mess clears up, I think Trinity comes back. I think that's the kind of stock you buy. ... I'm not backing away."'Nastech Pharmaceutical (NasdaqGM: NSTK - News): 'I would prefer, if you want to speculate, that you speculate with Nastech Pharmaceutical.'American Standard (NYSE: ASD - News): 'I frankly don't know why the market hates it so much. ... I'm stickin' by. It's painful, but I'm stickin' by it.'LKQ (NasdaqGS: LKQX - News): 'I like your company. I would stick with it.'Yamana Gold (NYSE: AUY - News): 'I'll stick with Yamana.'
Bearish calls:
Boston Scientific (NYSE: BSX - News): 'They canceled an IPO. I don't like the balance sheet. This is not my favorite company in the group. Even at $13, I'm going to reiterate that I can't get behind the medical company Boston Scientific.'Spartan Motors (NasdaqGS: SPAR - News)Jones Soda (NasdaqCM: JSDA): 'They missed the quarter. You cannot miss the quarter and be a high-multiple stock. Not only did they miss the quarter -- they missed the last quarter. ... I cannot pull the trigger. ... Jones is in the penalty box.'Limited Brands (NYSE: LTD - News): 'Here's a company that's doing absolutely everything right, but no one cares. My take is this: The Limited is too cheap, but I can't think of a catalyst to turn this stock around.'St. Joe (NYSE: JOE - News): 'I cannot be in the stock. It's just not the place to be.'WCI Communities (NYSE: WCI - News)SuperGen (NasdaqGM: SUPG - News)Coeur d'Alene Mines (NYSE: CDE - News): 'I have never been a fan of Coeur d'Alene. They always issue a lot of stock. They never seem to go anywhere.'
Published By SeekingAlpha

Labels: ASD, AUY, BSX, CDE, FRO, Jim Cramer, JOE, Lightning Round, LKQX, LMT, LTD, Mad Money, NOC, NSC, NSTK, RTN, SPAR, SUPG, TRN, UNH

Here are 7 stocks for traders for Friday from TradingMarkets.com:
Google (NasdaqGS:GOOG - News) missed earnings on Thursday, announcing $3.56 EPS versus expectations of $3.59 EPS. GOOG's PowerRating is 6.
Boston Scientific (NYSE:BSX - News) reports earnings on Friday before the market opens; look for $0.19 EPS. BSX's PowerRating is 5.
Caterpillar (NYSE:CAT - News) should report $1.48 EPS on Friday morning. CAT's PowerRating is 4.
When Citigoup NYSE:C reports earnings on Friday morning, anaylsts will be watching for $1.13 EPS. C's PowerRating is 5.
Schlumberger (NYSE:SLB - News) is expected to announce $0.96 EPS when the company reports earnings tomorrow. SLB's PowerRating is 4.
Analysts are watching for Wachovia (NYSE:WB - News) to report $1.22 EPS on Friday before the market opens. WB's PowerRating is 5.
Whirlpool (NYSE:WHR - News) should report $1.83 EPS on Friday morning. WHR's PowerRating is 5.
PowerRatings (for Traders) are courtesy of TradingMarkets.com

Labels: BSX, CAT, Hot Stocks, SLB, WB, WHR

Boston Scientific Corp. has reached an agreement to pay upwards of $195 million to settle more than 4,000 lawsuits it faces tied to faulty heart defibrillators, the company said Friday.
The spate of lawsuits were filed against Guidant Corp., which has a cardiac rhythm management unit based in Arden Hills. The company ultimately recalled more than 100,000 defibrillators, a move that contributed to a downturn in the market for the devices.
Natick, Mass.-based Boston Scientific (NYSE: BSX - News) inherited the legal troubles when it acquired Guidant last year for $27.5 billion.
The first case was set to go to trial in Minneapolis at the end of the month.
Several cases filed against the company in Texas will not be covered in the settlement, according to a report by Bloomberg.
Boston Scientific, which makes medical devices, said in August of last year that it had set aside $381 million to cover legal expenses related to the charges. The company's cardiovascular division is based in Maple Grove.
"We are pleased by this resolution, which is in the best interest of all involved," said Jim Tobin, President and CEO of Boston Scientific. "It will better allow us to focus our time and resources on developing innovative products to serve physicians and patients."
Published July 13, 2007 by the Minneapolis / St. Paul Business Journal

Labels: Boston Scientific Corp., BSX

Time Heals all Wounds: Kinetic Concepts (NYSE: KCI - News) and Smith & Nephew (NYSE: SNN - News)
Although Cramer usually prefers medical stocks which are a "pastiche," he likes KCI as a speculative stock even though it is levered only to wound-care and therapeutic service products. He is not concerned about the "nasty beating" KCI has taken, since the bulls and bears tend to fight it out over companies like KCI, and Cramer thinks the bulls will win. Another concern is KCI has reached 90% saturation in wound care and now has to compete for market share with SNN which recently acquired Blue Sky Medical. Cramer believes KCI has many competitive advantages, its 3% drop was "overdone," and only 10% of its revenue comes from bandages. He is confident KCI will bounce back.
On the Mend: Micrus Endovascular (NasdaqGM: MEND), Boston Scientific (NYSE: BSX - News) and Johnson & Johnson (NYSE: JNJ - News)
While those holding the stock may be in the "House of Pain" after MEND failed to get approval in China for its cerebral aneurysm treatment, Cramer thinks its $2 fall is a good opportunity to buy. He believes approval has been postponed and not cancelled, and would sell into strength once the treatment is approved. Cramer is not worried about large competitors BSX and JNJ. He also notes MEND could be a takeover target; "It either makes you money or it will get bought out." Cramer would buy the stock in increments andwould use limit orders.
Game Plan for the Coming Week: Thermo Fisher Scientific (NYSE: TMO - News), J.C. Penney (NYSE: JCP - News), Kohl's (NYSE: KSS - News), Home Depot (NYSE: HD - News), TJX Companies (NYSE: TJX - News), Jack in the Box (NYSE: JBX - News), Deere (NYSE: DE - News)
Cramer would look into buying scientific-instruments producer TMO before its analyst meeting on Tuesday. He also likes retailers JCP, KSS which report Thursday, and he thinks the downside has been priced into the stocks. Cramer is currently bullish on retail, and would buy half a position in HD before its Tuesday report, since he believes its management is developing "retail-savvy." Tuesday is also the day Cramer believes investors will see a "terrific" report from TJX and a "gigantic beat" from JBX, and he would buy ahead. However, Cramer would wait until after DE's report on Wednesday before buying, because the stock has increased, and he would wait for a selloff and a price drop.
CEO Interview: Mark Shapiro, Six Flags (NYSE: SIX - News)
Mark Shapiro is looking forward to an "extremely good summer season" given the number of group sales and season passes SIX has already sold. Meanwhile, the company has been investing in more aggressive marketing, employee training and recruiting. Although the weather is an unknown variable, Shapiro's aim is to "increase value proposition for our guests." Cramer remarks Shapiro is "good to go" and is sticking with Six Flags.

Published By SeekingAlpha

Labels: BSX, DE, HD, JBX, JCP, Jim Cramer, JNJ, KCI, KSS, Mad Money, SIX, SNN, TJX, TMO

Blue Chip stocks as measured by the Dow Jones Industrial Average inched upward to another record close, but stocks were otherwise mixed today as the technology sector closed fractionally lower. Oil prices inched down, but the 10-year Treasury note gained.
The Dow set its 20th record close since the beginning of the year. Part of the Dow's boost came from a hostile bid by Alcoa (NYSE: AA), a Dow component, for its Canadian rival Alcan (NYSE: AL). Alcoa offered an unsolicited bid of $26.9 billion for its cross-border competitor. Were the bid to be successful -- and Wall Street was betting today that the price would go higher -- the combined companies would control 20% of the world's aluminum production and would put back together companies split up over antitrust concerns years ago. Alcoa said it would address those issues by divesting itself of other assets. Alcoa's cash-and-stock offer valued Alcan at $73.25 a share, but investors quickly bid up the price of Alcan's stock above that level. Alcoa's shares also closed 8.3% higher.
Another factor that will drive trading this week will be the Federal Reserve, which meets on Tuesday and Wednesday to discuss interest rates and the economy. Most observers expect the Fed to hold the line on rates once again, but investors will be closely watching for any indications of a sentiment change from the central bank.
In other news, Johnson & Johnson (NYSE: JNJ) closed lower after announcing that a new drug-coated stent being developed by its Conor MedSystems unit had failed a key trial and would be pulled from overseas markets. Stents are used by heart surgeons to open up clogged arteries and keep blood flowing. Plans to introduce the new stent into the U.S. were also shelved. Some analysts suggested the announcement wasn't a major financial blow because the product was only expected to be a modest contributor over the next 12-18 months. Shares of Boston Scientific (NYSE: BSX) and Abbott Laboratories (NYSE: ABT), which offer competing products, rose on the news.
In the tech sector, Yahoo (Nasdaq: YHOO) backtracked following Friday's advance that was driven by rumors that it's talking to Microsoft (Nasdaq: MSFT) about some sort of linkage that would enable the two companies to better blunt Google (Nasdaq: GOOG).
Chipmaker Marvell Technologies (Nasdaq: MRVL) gained 1.1% after the company announced management changes to address problems stemming from its stock-option program. The company's board said its options problems were the result of a "systemic failure of internal controls." Marvell's CFO quit and the company fired the general counsel of its U.S. subsidiary. Co-founder Sehat Sutardja was asked to give up the chairman's title, but remains as CEO. Co-founder Weili Dai will assume a "significantly reduced role."
Finally, Berkshire Hathaway (NYSE: BKR-B) held its annual meeting over the weekend, during which CEO Warren Buffett commented that he's shopping for a huge deal in the $40-$60 billion range, but he's having trouble finding the right candidate. He also talked about succession plans, though he has no immediate plans of stepping down.

Labels: AA, ABT, AL, BSX, GOOG, JNJ, MRVL, YHOO

Boston Scientific Corp. on Monday said its first-quarter profit fell by 64 percent on costs from the company's $27 billion acquisition of Guidant Corp. last spring, as well as weak sales of the medical device maker's heart stents and defibrillators.
Natick-based Boston Scientific said net income for the January-through-March period was $120 million, or 8 cents per share, compared with a profit of $332 million, or 40 cents per share, in the same period a year ago. The per-share profit in the latest period was hurt because the company now has 1.5 billion outstanding shares as a result of the Guidant deal, compared with 830 million a year ago.
Net sales rose 26 percent to $2.086 billion from $1.62 billion in the year-ago period -- a result boosted in part by the additional business Boston Scientific took on with its Guidant acquisition. That result narrowly beat the consensus estimate of analysts surveyed by Thomson Financial, who expected sales of $2.079 billion in the latest quarter.

Labels: Boston Scientific Corp., BSX

Here are 7 stocks for traders for Monday from TradingMarkets.com:
Arch Coal (NYSE:ACI) reports earnings on Monday before the bell; watch for $0.16 EPS. ACI's PowerRating is 8.
Hasbro (NYSE:HAS) is expected to report $0.00 (flat) EPS on Monday before the market opens. HAS's PowerRating is 5.
When Kimberly-Clark (NYSE:KMB) announces earnings on Monday morning, be looking for $1.01 EPS. KMB's PowerRating is 5.
When L-3 Communications (NYSE:LLL) reports earnings before the bell Monday, watch for $1.28 EPS. LLL's PowerRating is 4.
Analysts are watching for Novartis AG (NYSE:NVS) to report $0.82 EPS before the market opens on Monday. NVS's PowerRating is 5.
Boston Scientific (NYSE:BSX) and Texas Instruments (NYSE:TXN) both report earnings after the bell on Monday, so watch for heightened price action and volume ahead of the close. BSX's PowerRating is 4, and TXN's PowerRating is 5.
PowerRatings are courtesy of PowerRatings.net

Labels: ACI, BSX, HAS, Hot Stocks, KMB, LLL, NVS, TXN

Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Research In Motion (NasdaqGS:RIMM - News). RIMM's PowerRating is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Krispy Kreme (NYSE:KKD - News). KKD's PowerRating is 7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Urban Outfitters (NasdaqGS:URBN - News) & Jinpan (NYSE:JST - News). URBN's PowerRating is 7, and JST's PowerRating is 8.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Intuit (NasdaqGS:INTU - News). INTU's PowerRating is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Boston Scientific (NYSE:BSX - News). BSX's PowerRating is 3.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Capital One Financial (NYSE:COF - News). COF's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: BSX, COF, Hot Stocks, INTU, JST, KKD, RIMM, URBN

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Hilton Hotels (NYSE:HLT - News). HLT's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Las Vegas Sands (NYSE:LVS - News). LVS's PowerRating is 7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Capital Trust (NYSE:CT - News) & Rockwell Collins (NYSE:COL - News). CT's PowerRating is 7, and COL's PowerRating is 7.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
LJ International (NasdaqGM:JADE - News). JADE's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
NewMarket Corporation (NYSE:NUE - News). NUE's PowerRating is 6.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Boston Scientific (NYSE:BSX - News). BSX's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: BSX, COL, CT, HLT, Hot Stocks, JADE, LVS, NUE

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Hilton Hotels (NYSE:HLT - News). HLT's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Las Vegas Sands (NYSE:LVS - News). LVS's PowerRating is 7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Capital Trust (NYSE:CT - News) & Rockwell Collins (NYSE:COL - News). CT's PowerRating is 7, and COL's PowerRating is 7.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
LJ International (NasdaqGM:JADE - News). JADE's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
NewMarket Corporation (NYSE:NUE - News). NUE's PowerRating is 6.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Boston Scientific (NYSE:BSX - News). BSX's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: BSX, COL, CT, HLT, Hot Stocks, JADE, LVS, NUE

The volatility of the first quarter that ended Friday, was reflected in several stocks that saw unusual activity during the week, including a drop for Boston Scientific and a jump for Abbott Laboratories.
Boston Scientific Corp. slid 6.6 percent Monday after a study showed a heart stent made by Abbott had lower rates of target vessel failure. This means the drug-coated stent performed better than Boston Scientific's Taxus.
The study was originally meant to show that the Abbott stent, called Xience, was merely not inferior to Taxus. Both stocks traded with very heavy volume, and sent shares of other stent makers into accelerated trading as well.
Shares of Boston Scientific sank to a nearly five-year low of $13.88 on the news, with volume approaching three times its typical trade of about 12 million shares. The New York Stock Exchange-listed shares recovered slightly as the week continued as volume returned to more normal levels, ending the week at $14.54.
Meanwhile, Abbott shares on Monday gained 6 percent and hit an all-time high of $57.26, with trading volume almost four times a typical day. Volume remained high Tuesday as shares began to slip a bit, and by Friday the stock settled back to close at $55.80, still up 3.6 percent for the week.
Nuvelo Inc. shot up 25 percent Tuesday to $3.86, after the smallcap company said the Food and Drug Administration has granted "fast-track" status to its colon cancer drug candidate as both a first- and second-line treatment.
That means Nuvelo can submit data to the FDA on a rolling basis rather than all at once, speeding up the application process.
Trading volume jumped to about 9 times its usual volume, with 28 million shares changing hands on the Nasdaq Stock Market. Activity remained high Wednesday, though volatility leveled out. The stock gave back some of its Tuesday gains but ended the week up 19 percent at $3.68.
On Wednesday, Beazer Homes USA Inc. plunged more than 8 percent to $28.77 on the NYSE, after the FBI said it is among agencies investigating possible fraud in the company's mortgage lending practices and other financial transactions.
The homebuilder said it was cooperating with a federal prosecutor's request for documents. The news came on top of ongoing struggles for the Atlanta-based company, which has suffered hefty losses amid a downturn in the housing market.
Trading volume swelled to 19.6 million shares changing hands, from a typical level of 1.6 million shares.
The U.S. attorney's office in Charlotte, N.C., along with the Internal Revenue Service and the U.S. Department of Housing and Urban Development are also participating in the investigation.
Volume settled back down the rest of the week, though the stock didn't recoup much of the loss. Shares of Beazer ended the week down 7.6 percent at $29.03.
RF Micro Devices Inc., which makes components used in mobile phones, on Thursday shed 11 percent to end at $6.31 on the Nasdaq, after the company projected a first-quarter slowdown. Trading volume zoomed to 63.3 million shares, from a usual 8.7 million shares changing hands.
The news prompted a Jefferies analyst to downgrade the stock. The company blamed lighter demand from a top customer, but did not provide more details. Analysts suspect the customer is mobile phone maker Motorola Inc., which recently warned of a more than $1 billion expected sales miss.
Shares lost another 8 cents Friday, with volume nearing 40.6 million shares, to close the week at $6.23.
Friday, Dendreon Corp. more than doubled its share price with extraordinarily heavy trading volume, surging $7.71 to $12.93 on the Nasdaq, and during the session spiked to $18.05, its highest point since December 2000. Volume approached 92.5 million shares, more than the 75.7 million shares the company had outstanding
The drug maker said a Food and Drug Administration panel endorsed its experimental prostate cancer vaccine, Provenge. The FDA advisers said the vaccine is safe, and said there is substantial evidence that it works in treating advanced prostate cancer that no longer responds to hormone treatment. The drug needs further study before it can be approved.
Published By AP

Labels: ABT, BSX, BZH, DNDN, MOT, NUVO, RFMD

Here are 7 options to watch for today. This list comes directly from the TradingMarkets Options Indicators page. The list is created using OptionVue options analysis software.
Most Under Priced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
Neurochem Inc. May 35 Calls (NasdaqGM:NRMX - News). NRMX's PowerRating is 5.
Most Under Priced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
United Therapeutics Apr 55 Puts (NasdaqGS:UTHR - News). UTHR's PowerRating is 6.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
Apple Inc. May 100 Calls (NasdaqGS:AAPL - News). AAPL's PowerRating is 4.
Baidu.com May 110 Calls (NasdaqGM:BIDU - News). BIDU's PowerRating is 4.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Oil Services HOLDRs May 135 Puts (AMEX:OIH - News). GOOG's PowerRating is 5.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
Boston Scientific Corp. (NYSE:BSX - News) . BSX's PowerRating is 5.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock.
None Today
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
Halliburton (NYSE:HAL - News). HAL's PowerRating is 4.
PowerRatings are courtesy of TradingMarkets.com

Labels: AAPL, BIDU, BSX, HAL, NRMX, OIH, stock options, UTHR

Symbol
Name
Last Trade
Change
Volume
Related Info
SPY
S&P DEP RECEIPTS
143.62 3:48PM ET
0.23 (0.16%)
104,420,881
Chart, Profile, More
QQQQ
NASDAQ 100 TR SER I
44.27 3:53PM ET
0.15 (0.34%)
102,026,086
Chart, Profile, More
SUNW
SUN MICROSYS INC
6.23 3:53PM ET
0.04 (0.65%)
53,124,479
Chart, Profile, More
CMGI
CMGI INC
2.48 3:53PM ET
0.28 (12.73%)
51,639,338
Chart, Profile, More
MSFT
MICROSOFT CP
28.15 3:53PM ET
0.13 (0.46%)
39,565,097
Chart, Profile, More
CSCO
CISCO SYS INC
26.30 3:53PM ET
0.11 (0.42%)
40,547,703
Chart, Profile, More
IWM
ISHARE RUS 2000 INDX
80.25 3:48PM ET
0.01 (0.01%)
41,333,486
Chart, Profile, More
INTC
INTEL CP
19.26 3:53PM ET
0.01 (0.05%)
35,173,169
Chart, Profile, More
MOT
MOTOROLA INC
17.95 3:48PM ET
0.20 (1.13%)
33,348,600
Chart, Profile, More
BSX
BOSTON SCIENTIFIC CP
14.14 3:48PM ET
1.08 (7.10%)
32,823,250
Chart, Profile, More
DELL
DELL INC
23.60 3:53PM ET
0.77 (3.37%)
32,600,109
Chart, Profile, More
F
FORD MOTOR CO
7.89 3:48PM ET
0.00 (0.00%)
31,382,894
Chart, Profile, More
HAL
HALLIBURTON CO
31.32 3:48PM ET
0.24 (0.77%)
25,268,696
Chart, Profile, More
PFE
PFIZER INC
25.73 3:48PM ET
0.07 (0.27%)
27,678,148
Chart, Profile, More
ORCL
ORACLE CORP
18.32 3:53PM ET
0.08 (0.44%)
29,026,499
Chart, Profile, More
AAPL
APPLE INC
95.73 3:53PM ET
2.21 (2.36%)
28,954,336
Chart, Profile, More
LSI
L S I LOGIC CP
10.09 3:48PM ET
0.18 (1.75%)
29,152,449
Chart, Profile, More
TWX
TIME WARNER INC
20.20 3:48PM ET
0.40 (2.02%)
26,816,208
Chart, Profile, More
GE
GEN ELECTRIC CO
35.97 3:48PM ET
0.15 (0.42%)
27,788,583
Chart, Profile, More
XOM
EXXON MOBIL CP
75.53 3:48PM ET
0.51 (0.67%)
22,214,810
Chart, Profile, More

Labels: AAPL, BSX, CMGI, CSCO, DELL, F, GE, HAL, INTC, IWM, LSI, MOT, MSFT, ORCL, pfe, QQQQ, SPY, SUNW, TWX, XOM

Bullish calls:
Cleveland-Cliffs (NYSE: CLF - News): 'Cheap, cheap, cheap, cheap, cheap! This is an iron pellet company, and there is a worldwide shortage of iron ... I believe that CLF - if it does not get the stock higher - will be purchased by another company - buy buy buy!'Vodafone (NYSE: VOD - News): 'I think the 3% yield, plus the incredible assets it has in Europe yields a buy, and I would buy the stock.'Gilead Sciences (NasdaqGS: GILD)Celgene (NasdaqGS: CELG): 'I've got the CELG at $55.'Genzyme (NasdaqGS: GENZ)Infosys Technologies (NasdaqGS: INFY): 'You know that's one of my favorite outsourcing companies! Now there are a lot of people who won't want to put money in Bangalor... I think those people are short-sighted.'Accenture (NYSE: ACN - News): ' ... you could always do ACN, ahead of next week's quarter, which I think will be good.'Six Flags (NYSE: SIX - News): 'They reported a quarter that everyone said was bad. And did the stock blink an eye? Absolutely not. I am with you. I believe the comparisons will be really easy for SIX. Pull the trigger my friend.'Sun Microsystems (NasdaqGS: SUNW): 'I think SUNW is okay. This is a new position for me. I have historically disliked SUNW... At $6 bucks, I don't know... enough hate is enough. They've got a new CEO. They've got a KKR shareholder. I think there's a lot of ways to win. $1 down, $3 up.'Indevus Pharmaceuticals (NasdaqGM: IDEV): 'I recommended IDEV... and it is still ramping... but it's a little $6 stock, so I'm not going to push it hard here. They've got a lot of compounds... I would take a shot. It's a flyer. It's a speculative name.'Apple (NasdaqGS: AAPL): 'If it's going to $100 and beyond, I don't think $93 is a bad level, but let's do it this way: Let's buy 25 shares, with the hope it comes in so we can get our 100 shares in... I think iPhone is going to be gigantic. 'Amgen (NasdaqGS: AMGN): 'I say buy it here with a minimum risk/reward. Maybe even do it in deep-in-the-money in options.'
Bearish calls:
Boston Scientific (NYSE: BSX - News): ' We pulled the trigger, and told people to sell at $18, and I am not changing my mind. I still don't like BSX, even down here at $15. Sell, sell, sell!'Baidu.com (NasdaqGM: BIDU): 'I can never trust the communist Chinese communists to allow a free-speech internet to be able to prosper... which is why I refuse to endorse BIDU. Don't buy, don't buy.'Pozen (NasdaqGM: POZN): ' Too dicey, ever since they did that migraine game... I've got the CELG at $55. That's better. I like the GILD better too. And let's not forget GENZ!Nokia (NYSE: NOK - News): 'NOK is falling apart.'Motorola (NYSE: MOT - News): 'MOT is competely and utterly just (house of pain)।'
Published by SeekingAlpha

Labels: AAPL, ACN, BIDU, BSX, CLF, IDEV, Jim Cramer, Lightning Round, Mad Money, MOT,